Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/13/2019
NACDS highlights pharmacists’ role in fighting substance use disorder
In detailed letters to 15 Medicaid program directors. NACDS called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain. - 11/12/2019
Abbott Labs CEO to step down, company names successor
After 21 years, Miles White is stepping down as Abbott’s CEO next March. The company has named Robert Ford as his successor. - 11/12/2019
Fresenius Kabi introduces generic Emend
Fresenius Kabi's generic Emend provides clinicians with a treatment alternative that has a 24-month shelf life. - 11/12/2019
Consortium led by Wasson Enterprise to acquire majority stake in Innovation
A group of investors led by Greg Wasson, former Walgreens Boots Alliance CEO will acquire a majority stake in Innovation Associates. - 11/11/2019
Bartell Drugs launches Instacart delivery
Bartell's, which introduced NimbleRx for prescription delivery early this year, is launching Instacart. - 11/11/2019
Teva taps Eli Kalif as executive vice president, CFO
Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22. - 11/11/2019
Mylan-Upjohn combination to be called Viatris
The Viatris name will be effective upon closing of the combination of Mylan and Upjohn, which is expected to occur in mid 2020. - 11/11/2019
Diplomat posts Q3 loss along with drop in PBM segment
Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment - 11/11/2019
Breckenridge gets FDA green light for generic Tarceva
Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019. - 11/10/2019
Glenmark gets FDA nod for generic Epiduo
Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA.
